BioGenex Laboratories Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • BioGenex Laboratories's estimated annual revenue is currently $44M per year.(i)
  • BioGenex Laboratories's estimated revenue per employee is $155,000

Employee Data

  • BioGenex Laboratories has 284 Employees.(i)
  • BioGenex Laboratories grew their employee count by 7% last year.

BioGenex Laboratories's People

NameTitleEmail/Phone
1
Cofounder and Director BoardReveal Email/Phone
2
Senior ManagerReveal Email/Phone
3
Chairman, CEO and FounderReveal Email/Phone
4
Sales Manager-New EnglandReveal Email/Phone
5
Talent Acquisition and Employee RelationsReveal Email/Phone
6
Financial AnalystReveal Email/Phone
7
Research AssociateReveal Email/Phone
8
technicianReveal Email/Phone
9
Senior EngineerReveal Email/Phone
10
Strategic Alliances and PartnershipsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is BioGenex Laboratories?

For over two decades BioGenex has been diligently serving the needs of clinical diagnostics with novel technologies for Cell and Molecular Pathology. BioGenex continues to be a premier customer service provider and is continually striving towards excellence. We are proud to be the only company that provides a "Total Solution" for automated cell and tissue analysis. Our automated systems streamline operations in anatomic pathology and provide effective tools for the detection and diagnosis of cancer and infectious diseases. In recent years, we have developed automated systems for drug discovery and development laboratories allowing high-throughput drug target characterization and histological profiling of genes and proteins. Along with automated systems, we provide a wide range of products including over 300 antibodies, highly sensitive detection kits, tissues and Tissue Microarrays (TMA), and cutting-edge imaging systems for cell and TMA analysis. Furthermore, as inventors of antigen retrieval, we also offer a wide variety of antigen retrieval solutions for difficult to stain tissues. Our commitment is to provide the most innovative and cost-effective solutions to our customers. We serve many leading laboratories and research organizations throughout the world and are committed to providing excellent quality products to our customers. Our dedicated team of employees strives to bring BioGenex to the forefront of Cell and Molecular Pathology in Clinical Diagnostics, Drug Discovery, and Life Science Research. I invite you to learn more about BioGenex through this website and watch for the company’s future developments.

keywords:N/A

N/A

Total Funding

284

Number of Employees

$44M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

BioGenex Laboratories News

2022-04-20 - In-situ Hybridization (ISH) Market 2022 Share Growing ...

ABBott Laboratories, F.Hoffmann-La Roche, Thermofisher Scientific, ... Exiqon, Biogenex Laboratories, Advanced Cell Diagnostics, Bio SB.

2022-04-19 - In situ Hybridization Market Size, Outlook And Forecast ...

Abbott Laboratories, Thermofisher Scientific, F. Hoffmann-La Roche Ltd., Bio-Techne Corporation, Biocare Medical, BioGenex Laboratories,...

2022-04-19 - In Situ Hybridization Market Size, Scope And Outlook | ABBott ...

... Elmer Danaher Corporation / Leica Biosystems Nussloch GmbH, Exiqon A/S, Biogenex Laboratories Advanced Cell Diagnostics, Bio Sb, Inc.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$45.3M2843%N/A
#2
$102.2M2860%N/A
#3
$85.8M2899%N/A
#4
$98.6M2949%N/A
#5
$64.7M2955%$27M